Hypertrophic osteoarthropathy in staging skeletal scintigraphy for lung cancer.
OBJECTIVE
To assess the prognostic significance of hypertropic osteoarthropathy (HOA) discovered on routine staging bone scintigraphy in patients with lung cancer.


METHODS
Between 1989 and 1992 all 99mTc-MDP bone scintigrams performed for the staging of bronchogenic carcinoma were reviewed. HOA was diagnosed by the observation of cortical/periosteal increased uptake in the extremities of the long bones. Follow-up and confirmation of the diagnosis was obtained by hospital computer, histology records, operative records, patient notes and radiological data where available.


RESULTS
164 staging scintigrams for lung cancer were identified. Twenty-eight patients (17%) were observed to have HOA. Patients with and without HOA were well matched for age and sex. There was little difference in the distribution of cell type but the HOA groups has a greater incidence of peripheral tumours. There was no significance in survival between the two groups. Two of three long-term survivors had clinically overt HOA and one presented with arthralgia.


CONCLUSIONS
HOA is often seen on skeletal scintigraphy for staging of lung cancer and has no prognostic significance. The data also support current teaching that a high index of suspicion for HOA, as a cause of arthralgia may lead to early diagnosis of a potentially resectable lung carcinoma.
Morgan
B
B
Department of Radiology, Leicester Royal Infirmary NHS Trust, UK.
Coakley
F
F
Finlay
D B
DB
Belton
I
I
D000368:Aged; D000369:Aged, 80 and over; D002283:Carcinoma, Bronchogenic / Q000150:complications / Q000000981:diagnostic imaging*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications / Q000000981:diagnostic imaging*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010005:Osteoarthropathy, Secondary Hypertrophic / Q000000981:diagnostic imaging* / Q000209:etiology; D010257:Paraneoplastic Syndromes / Q000000981:diagnostic imaging* / Q000209:etiology; D011379:Prognosis; D011877:Radionuclide Imaging; D015996:Survival Rate; D013669:Technetium Tc 99m Medronate
D013669:Technetium Tc 99m Medronate